Neoadjuvant and Adjuvant Therapy for HER2 Positive Disease.
Chia, Stephen K
Neoadjuvant and Adjuvant Therapy for HER2 Positive Disease. [electronic resource] - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2015 - e41-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1548-8756
10.14694/EdBook_AM.2015.35.e41 doi
Antineoplastic Agents--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Female
Humans
Neoadjuvant Therapy
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Mas
Receptor, ErbB-2--antagonists & inhibitors
Trastuzumab--therapeutic use
Neoadjuvant and Adjuvant Therapy for HER2 Positive Disease. [electronic resource] - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2015 - e41-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1548-8756
10.14694/EdBook_AM.2015.35.e41 doi
Antineoplastic Agents--therapeutic use
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Female
Humans
Neoadjuvant Therapy
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Mas
Receptor, ErbB-2--antagonists & inhibitors
Trastuzumab--therapeutic use